ITAT: Forfeited trade advance received in normal course of stressed-assets’ business, not chargeable u/s 68

• In Favour of Assessee
• Citation Number : TS-1612-ITAT-2025(Mum)

NCLT: Rejects shareholder’s Sec. 244 waiver plea in oppression-mismanagement case; Cites 'general/vague' allegation

NCLAT: Refuses to condone RD's 9-month delay in challenging NCLT’s amalgamation order

HC: No full & true disclosure of income in settlement application; Affirms Commission's application rejection

• In Favour of Revenue
• Citation Number : TS-1611-HC-2025(MAD)

SC: PwD rights reflect equality, directs UPSC to frame protocols for use of screen-reader software

SC: Muslim woman entitled to return of money and gold given at marriage after divorce

SC: Police and Criminal Courts must avoid filing charge-sheets in cases where civil dispute pending

SC: Power to acquire land u/s 14 Slum Act is subject to owner’s preferential right to develop

SC: Attachment before judgment remedy cannot extend to property alienated prior to filing of suit

SC: Jurisdiction for complaint u/s 138 NI Act for a/c payee cheque vests basis Payee’s Home-Branch location

HC: Upholds award holding party in breach of Agreement over ‘failure to endeavour’ to achieve revenue projections

GSTN issues update on auto-suspension of registration for missing bank account information

ITAT: Holds Pr.CIT’s Sec.263 order as unsustainable, no prejudice once expenses recovered from AE with mark-up

• In Favour of Assessee
• Citation Number : TS-715-ITAT-2025(PUN)-TP

ITAT: Rejects NIL ALP for management fee, directs verification of assessee's benchmarking using 'other method'

• In Favour of Assessee
• Citation Number : TS-716-ITAT-2025(Mum)-TP

ITAT: Views rectification sought is in nature of review, outside scope of Sec. 254(2)

• In Favour of Revenue
• Citation Number : TS-717-ITAT-2025(HYD)-TP

AAR: Customs pre-consultation letter not a valid document to claim ITC of differential duty

• In Favour of Respondent
• Citation Number : TS-985-AAR(GUJ)-2025-GST

HC: Holds Revenue empowered to administer oath u/s 131, but deletes additions made basis 'vague' statements

• In Favour of Assessee
• Citation Number : TS-1610-HC-2025(MAD)

GSTN issues advisory and FAQs on reporting values in Table 3.2 of GSTR-3B

HC: Rejects Novo Nordisk’s patent injunction plea, allows Dr. Reddy’s to make, export ‘Ozempic’ like drug

NCLT: No explicit bar on appointing common RP for group-entities; Rejects ex-Promoter’s plea for removal